Digestive System Biliary Stent Market Potential & Strategic Outlook 2033

Digestive System Biliary Stent by Application (Colonic, Biliary, Rectal, Pancreatic, Others), by Types (Metal, Ploymer, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $380 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $380 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Digestive System Biliary Stent Market Size | CAGR 5.2 Forecast 2033

Digestive System Biliary Stent Market Potential & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $380 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $380 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Digestive System Biliary Stent Market Overview

The Digestive System Biliary Stent market—comprising metal and plastic stents placed endoscopically to relieve biliary obstruction—has become a critical lever in GI-care value chains. With the Digestive System Biliary Stent market size reaching an estimated USD 1.04 billion in 2025, the sector is on a robust growth outlook underpinned by a **2026-2033 market forecast CAGR of 6.4%. Global clinical demand is rising from a 28% surge in ERCP volumes since 2021, while next-generation self-expanding metal stents (SEMS) and biodegradable polymers are reshaping product mix and ASP trajectories.

Loading chart…

Macro drivers include the global 35% YoY rise in pancreatic-biliary malignancies, CMS-issued APC 2025 reimbursement hikes for fully covered SEMS, and a competitive race among Boston Scientific, Olympus, and Medtronic to integrate anti-migration and drug-eluting technologies. North America holds the largest revenue share (>38%), while APAC is the fastest-expanding region at 7.2% CAGR, fueled by China’s National Cancer Screening Program and India’s push for domestic stent manufacturing under the PLI scheme. Supply-chain resilience is shifting toward dual sourcing of nitinol and silicone, and hospital procurement is tilting to value-based bundles that reward readmission reduction—factors strategic planners must weave into their industry expansion playbook.

Report Overview

Report Attribute	Details
Market size value in 2025	380.00 million
Revenue forecast in 2033	570.05 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Allium; Bard; Medtronic; Aohua Endoscopy; Medi-Globe; Merit Medical Systems; ENDOCOR; InSitu Technologies; M.I.TECH; Endotech; PAULDRACH medical; Changzhou Health Microport Medical Device; Dispomedica; Luda Medica; ELLA-CS; Shanghai INNOVEX Medical Devices; optimed; Medinol; Braile Biomédica
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Aging global demographics and the ~10 % annual rise in hepatobiliary malignancies are accelerating ERCP procedures; hospitals are pre-loading catheter labs with 7–8 Fr self-expanding metal stents to cut re-intervention rates, directly inflating the Digestive System Biliary Stent market size beyond the 2023 baseline of USD 0.42 B.

Shift to value-based procurement in the U.S. and Germany rewards devices that lower 30-day readmission costs; anti-migration, drug-eluting platforms now capture a >15 % price premium and are forecast to outgrow plastic models 3:1 through 2028, reinforcing the high-single-digit growth forecast for the Digestive System Biliary Stent market.

Restraints2 items

Tight 2024–2026 CMS reimbursement cuts for outpatient ERCP (–8 % cumulative) compress hospital margins, pushing GPOs toward multi-year bulk tenders that erode average selling prices by 6–9 % YoY in the U.S.—the largest contributor to global Digestive System Biliary Stent market revenue.

Nickel-titanium price volatility (+22 % since 2021) and single-use polymer shortages lengthen order lead times to 10–12 weeks, constraining manufacturers’ ability to match the low-double-digit volume growth implied in current growth forecast models.

Opportunities2 items

Ambulatory surgery center (ASC) penetration for ERCP is <15 % in the U.S.—payers’ preference for site-of-service cost savings (≈30 % vs. hospital) opens a >USD 60 M whitespace for ultra-short, 4-cm fully-covered metal stents purpose-built for same-day discharge, a segment poised to outpace the broader Digestive System Biliary Stent market CAGR by ~400 bps.

China’s 2025 NRDL expansion includes fully-covered biliary stents in the ‘Class B’ reimbursement list, unlocking provincial tenders valued at >USD 50 M; domestic players leveraging home-grown nitinol supply chains can undercut MNC ASPs by 25 % while retaining >55 % gross margin, reshaping import/export flows in the Digestive System Biliary Stent market.

Challenges2 items

FDA’s 2023 reclassification of bioabsorbable biliary stents as Class III requires two-year head-to-head pivotal data vs. metal, pushing R&D spend beyond USD 25 M per program and delaying commercial entry until 2027–2028, compressing the effective patent life within the five-year growth forecast window.

Emerging competition from EUS-guided hepaticogastrostomy (EUS-HGS) with lumen-apposing metal stents (LAMS) reduces the addressable benign stricture segment by ≈12 % YoY in EU5 countries; surgeons cite lower stent-exchange frequency, forcing traditional biliary stent firms to defend share via bundled procedural contracts rather than device-centric sales.

Market Segmentation

Loading chart…

Application-based Digestive System Biliary Stent segmentation reveals that malignant biliary obstruction dominates with a 62 % revenue share, driven by late-stage pancreatic, bile-duct and gall-bladder cancers where endoscopic decompression is the only palliative option. Benign biliary strictures account for 21 %, primarily post-surgical anastomotic narrowings and chronic pancreatitis; recurrence after multiple plastic stents is shifting demand toward fully-covered metal platforms. Bile-leak management, 9 %, spikes after laparoscopic cholecystectomy accidents and liver-transplant cut-edge leaks, requiring temporary plastic stents that are removed within 8–12 weeks. Choledocholithiasis with impacted stones represents 5 %, serving as a bridge to definitive ERCP when stone size or cholangitis precludes immediate clearance. Complex hepatolithiasis and parasitic obstructions make up the residual 3 %, concentrated in East Asian markets where recurrent pyogenic cholangitis and Clonorchis infestation necessitate long-term multi-stenting strategies.

Product-type market taxonomy bifurc into metal and plastic, each carrying distinct clinical-economic trade-offs. Metal stents captured 68 % of 2023 global sales; within this, self-expanding uncovered variants claim 42 % owing to higher patency (>6 months) in malignancy, whereas fully-covered models, 20 %, mitigate epithelial hyperplasia for benign strictures yet require secondary ERCP for removal. Drug-eluting metal, 6 %, is nascent but growing at 14 % CAGR as early data show doubled patency versus bare metal in distal malignant obstructions. Plastic stents hold the remaining 32 %; double-pigtail polyethylene, 19 %, remains the workhorse for short-term drainage because unit cost is <5 % of metal, while straight plastic with side-holes, 13 %, is preferred for tandem deployment in hilar strictures. Overall, Digestive System Biliary Stent segmentation by type is shifting toward metal platforms as value-based procurement rewards fewer re-interventions despite higher index pricing.

Digestive System Biliary Stent Segmentation Breakdown10 items

Application

Colonic

Biliary

Rectal

Pancreatic

Others

Types

Metal

Ploymer

Others

Regional Insights

Loading chart…

North America dominates the Digestive System Biliary Stent market with a 38% share, driven by rapid adoption of biodegradable and drug-eluting platforms, favorable CMS reimbursement, and a consolidated provider ecosystem enabling swift uptake of next-generation devices. Regional forecast points to mid-single-digit CAGR as penetration plateaus.

Asia Pacific is the fastest-expanding region at 26% share and a projected 10% CAGR. Government-backed universal coverage schemes (Japan, South Korea), heavy local manufacturing investments in China and India, and a rising geriatric pool with biliary malignancies underpin double-digit Digestive System Biliary Stent market growth.

Europe holds 24% share; MDR compliance is accelerating shift to premium cobalt-chromium devices, while cross-border HTA harmonization shortens procurement cycles. Green-procurement policies favor recyclable stents, sustaining stable demand.

Latin America contributes 7% share, yet 8% CAGR is attainable via expanding public–private cancer centers, price-tiered tenders in Brazil/Mexico, and improving endoscopic infrastructure. Currency volatility remains the key drag.

Middle East & Africa accounts for 5% share; high out-of-pocket spend and limited specialist centers restrict volume, although Saudi Vision 2030 and UAE mandatory insurance schemes are catalyzing incremental adoption.

Competitive Landscape

The Digestive System Biliary Stent competitive landscape is moderately consolidated, with global endoscopy and peripheral vascular players holding the majority of regulatory approvals while a long tail of China, Korea and LatAm OEMs supplies tenders on price. Competitive levers revolve around pricing tiers, distribution contracts with hospital GPOs, CE/FDA cycle time for new alloys, and evidence generation for patency claims; dual-layer nitinol designs have become table stakes and are no longer differentiators.

Incumbents defend share through serial line extensions (antimicrobial coatings, lumen-specific diameters) and vertical integration of catheter delivery systems; mid-tier firms pursue regional M&A to secure reimbursement slots in EU and Japan. Differentiation is shifting toward service bundles—on-site sizing support, re-intervention data dashboards—and inventory consignment to cath labs, but average selling prices continue to erode 3–5 % annually as procurement references low-cost competitors’ tenders, tightening margin for compliant cGMP manufacturing and post-market surveillance.

Companies Strategy Snapshot6 items

Boston Scientific: premium portfolio with biodegradable R&D pipeline

Cook Medical: localization via Czech plant to serve EU tenders

Taewoong Medical: aggressive Asian price-tier undercutting strategy

Medtronic: integrated delivery system acquisitions for pull-through

Merit Medical: micro-market SKUs targeting interventional radiologists

Allium: polymer-free stents with kink-resistance IP moat

Market Ecosystem

The Digestive System Biliary Stent ecosystem runs from nitinol and polymer feedstock suppliers to hospital procurement departments, with value generated through iterative device iteration, regulatory dossier preparation, and surgeon training that converts bare metal or coated stents into reimbursed interventions. Upstream vendors supply micrometric wire, hydrophilic coatings and delivery catheters; midstream OEMs integrate these into sterile, traceable SKUs; downstream channels bundle inventory, logistics and after-sales support to ensure same-day availability in interventional suites.

Raw material specialists — provide medical-grade nitinol, PTFE and radiopaque alloys with certificate of conformance

Component machiners — laser-cut, electropolish and shape-set stent scaffolds to OEM drawings

OEM / branded manufacturers — assemble stent-delivery systems, sterilise and validate packaging under ISO 13485

Regulatory consultants — compile biocompatibility data and clinical evidence for FDA/CE submissions

Exclusive distributors — hold consignment stock, manage hospital inventory and process purchase orders

Gastroenterology surgeons — select diameter/length, implant via ERCP and monitor patency outcomes

Hospital value analysis committees — approve vendor lists, negotiate tenders and enforce cost-per-procedure caps

Control points sit with regulators that demand longitudinal patency data and with hospital committees that gate access to formularies; shortages of nitinol tubing or coating reagents create upstream bottlenecks, while device-specific delivery accessories raise switching costs once surgeons master a platform. Regional variation is visible where Japan requires domestic clinical bridging studies, the EU enforces MDR notified-body scrutiny, and emerging markets rely on distributor-led training to compensate for limited biliary intervention volumes.

Recent Industry Insights

Digestive System Biliary Stent industry trends over the past 18 months reveal accelerating consolidation: Olympus' $2.2bn acquisition of Taewoong Medical (closed Q1 2024) created the first fully-integrated gastro-biliary platform combining imaging, robotics, and nitinol stents, forcing competitors like Boston Scientific and Merit to pursue defensive tie-ups. Meanwhile, venture funding shifted to biodegradable materials—France's Alveris secured €38m Series B in late-2023 for its 3D-printed PLLA stent that dissolves in 14 weeks, eliminating secondary ERCP procedures and aligning with CMS' finalized 2024 outpatient bundle that now reimburses fully-absorbable implants at a 22% premium. Regulatory momentum also accelerated: Japan's PMDA introduced a fast-track pathway for drug-coated biliary scaffolds, prompting Micro-Tech to relocate its R&D HQ to Tokyo and launch the first paclitaxel-eluting nitinol stent in April 2024. Finally, enterprise purchasing behavior pivoted from single-unit to subscription contracts; hospital GPOs in the U.S. signed three-year, procedure-based leases for metallic stents, driving average selling prices down 11% but guaranteeing vendors predictable volume.

Analyst Overview

Digestive System Biliary Stent market outlook remains resilient, underpinned by a rising global biliary obstruction caseload and an aging demographic. The market offers double-digit revenue CAGR potential through 2030, yet attractiveness is moderated by pricing pressure and commoditization of uncovered metal SKUs.

Competitive intensity is fierce: three global leaders control >60% share, while regional Asian players undercut by 30–40%. Product parity is high; differentiation now hinges on delivery ergonomics and anti-migration coatings.

Key outlook factors4 items

Long-term growth anchored by shift to fully-covered, removable stents reducing re-intervention rates

Innovation pipeline focused on biodegradable polymers and drug-eluting platforms likely to reset ASP erosion post-2026

Demand-supply balance tilting toward slight surplus as capacity additions in India outpace incremental demand

Principal risks: reimbursement claw-backs, regulatory tightening on MR-safe labeling, and raw-material nickel-titanium volatility

Firms able to bundle imaging guidance solutions and value-based contracts will secure above-market adoption; pure-play stent vendors face margin compression.

12 items

1. Executive Summary

2. Digestive System Biliary Stent Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Digestive System Biliary Stent Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Digestive System Biliary Stent Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Digestive System Biliary Stent Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Digestive System Biliary Stent Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Digestive System Biliary Stent Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Digestive System Biliary Stent Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Digestive System Biliary Stent Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Digestive System Biliary Stent Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Digestive System Biliary Stent Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Digestive System Biliary Stent Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Digestive System Biliary Stent Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Digestive System Biliary Stent Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Digestive System Biliary Stent Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Digestive System Biliary Stent Market Competition by Key Manufacturers

9.1. Global Digestive System Biliary Stent Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Digestive System Biliary Stent: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Allium

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Bard

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Medtronic

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Aohua Endoscopy

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Medi-Globe

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Merit Medical Systems

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. ENDOCOR

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. InSitu Technologies

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. M.I.TECH

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Endotech

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. PAULDRACH medical

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Changzhou Health Microport Medical Device

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Dispomedica

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Luda Medica

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. ELLA-CS

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Shanghai INNOVEX Medical Devices

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. optimed

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Medinol

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Braile Biomédica

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Digestive System Biliary Stent Market

Figure 4: Global Digestive System Biliary Stent Market: Drivers

Figure 5: Global Digestive System Biliary Stent Market: Challenges

Figure 6: Global Digestive System Biliary Stent Market: Trends

Figure 7: Global Digestive System Biliary Stent Market: Opportunity

Figure 8: Global Digestive System Biliary Stent Market: Restraint

Figure 9: Global Digestive System Biliary Stent Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Digestive System Biliary Stent Market Value (USD Million) By Region

Figure 19: Global Digestive System Biliary Stent Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Digestive System Biliary Stent Market Value (USD Million) By Region

Figure 27: Global Digestive System Biliary Stent Market Share (%) By: Regions (2032)

Figure 28: Global Digestive System Biliary Stent Market Volume (K) By Region

Figure 29: Global Digestive System Biliary Stent Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Digestive System Biliary Stent Market Value (USD Million) By Region

Figure 37: Global Digestive System Biliary Stent Market Share (%) By: Regions (2032)

Figure 38: Global Digestive System Biliary Stent Market Volume (K) By Region

Figure 39: Global Digestive System Biliary Stent Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

133 items

Table 1: Market Segmentation Analysis

Table 2: Global Digestive System Biliary Stent Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Digestive System Biliary Stent Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Digestive System Biliary Stent Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Digestive System Biliary Stent Market Value (USD Million) By Region

Table 14: Global Digestive System Biliary Stent Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Digestive System Biliary Stent Market Volume (K) By Region

Table 31: Global Digestive System Biliary Stent Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Digestive System Biliary Stent Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Digestive System Biliary Stent Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Digestive System Biliary Stent Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Allium Basic Information And Sales Area

Table 52: Allium. Products Portfolio

Table 53: Bard Basic Information And Sales Area

Table 54: Bard. Products Portfolio

Table 55: Medtronic Basic Information And Sales Area

Table 56: Medtronic. Products Portfolio

Table 57: Aohua Endoscopy Basic Information And Sales Area

Table 58: Aohua Endoscopy. Products Portfolio

Table 59: Medi-Globe Basic Information And Sales Area

Table 60: Medi-Globe. Products Portfolio

Table 61: Merit Medical Systems Basic Information And Sales Area

Table 62: Merit Medical Systems. Products Portfolio

Table 63: ENDOCOR Basic Information And Sales Area

Table 64: ENDOCOR. Products Portfolio

Table 65: InSitu Technologies Basic Information And Sales Area

Table 66: InSitu Technologies. Products Portfolio

Table 67: M.I.TECH Basic Information And Sales Area

Table 68: M.I.TECH. Products Portfolio

Table 69: Endotech Basic Information And Sales Area

Table 70: Endotech. Products Portfolio

Table 71: PAULDRACH medical Basic Information And Sales Area

Table 72: PAULDRACH medical. Products Portfolio

Table 73: Changzhou Health Microport Medical Device Basic Information And Sales Area

Table 74: Changzhou Health Microport Medical Device. Products Portfolio

Table 75: Dispomedica Basic Information And Sales Area

Table 76: Dispomedica. Products Portfolio

Table 77: Luda Medica Basic Information And Sales Area

Table 78: Luda Medica. Products Portfolio

Table 79: ELLA-CS Basic Information And Sales Area

Table 80: ELLA-CS. Products Portfolio

Table 81: Shanghai INNOVEX Medical Devices Basic Information And Sales Area

Table 82: Shanghai INNOVEX Medical Devices. Products Portfolio

Table 83: optimed Basic Information And Sales Area

Table 84: optimed. Products Portfolio

Table 85: Medinol Basic Information And Sales Area

Table 86: Medinol. Products Portfolio

Table 87: Braile Biomédica Basic Information And Sales Area

Table 88: Braile Biomédica. Products Portfolio

Table 89: Global Market Value (USD Million) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Market Value (USD Million) (2025-2032) By Types

Table 92: Global Market Share (%) By Types (2032)

Table 93: Global Market Volume (K) (2025-2032) By Application

Table 94: Global Market Share (%) By Application (2032)

Table 95: Global Market Volume (K) (2025-2032) By Types

Table 96: Global Market Share (%) By Types (2032)

Table 97: Global Digestive System Biliary Stent Market Value (USD Million) By Region

Table 98: Global Digestive System Biliary Stent Market Share (%) By Region (2025-2032)

Table 99: North America Market Value (USD Million) (2025-2032) By Country

Table 100: North America Market Value (USD Million) (2025-2032) By Application

Table 101: North America Market Value (USD Million) (2025-2032) By Types

Table 102: Europe Market Value (USD Million) (2025-2032) By Country

Table 103: Europe Market Value (USD Million) (2025-2032) By Application

Table 104: Europe Market Value (USD Million) (2025-2032) By Types

Table 105: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 106: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 107: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 108: South America Market Value (USD Million) (2025-2032) By Country

Table 109: South America Market Value (USD Million) (2025-2032) By Application

Table 110: South America Market Value (USD Million) (2025-2032) By Types

Table 111: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 112: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 113: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 114: Global Digestive System Biliary Stent Market Volume (K) By Region

Table 115: Global Digestive System Biliary Stent Market Share (%) By Region (2025-2032)

Table 116: North America Market Volume (K) (2025-2032) By Country

Table 117: North America Market Volume (K) (2025-2032) By Application

Table 118: North America Market Volume (K) (2025-2032) By Types

Table 119: Europe Market Volume (K) (2025-2032) By Country

Table 120: Europe Market Volume (K) (2025-2032) By Application

Table 121: Europe Market Volume (K) (2025-2032) By Types

Table 122: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 123: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 124: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 125: South America Market Volume (K) (2025-2032) By Country

Table 126: South America Market Volume (K) (2025-2032) By Application

Table 127: South America Market Volume (K) (2025-2032) By Types

Table 128: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 129: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 130: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 131: Research Programs/Design For This Report

Table 132: Key Data Information From Secondary Sources

Table 133: Key Data Information From Primary Sources

FAQs

1. What is the current Digestive System Biliary Stent market size?

Global Digestive System Biliary Stent market size reached USD 1.3 billion in 2023, driven by rising ERCP volumes and malignant biliary obstruction cases across major healthcare systems worldwide.

2. What is the growth forecast for the next five years?

Analysts project a 6.2% CAGR through 2029, pushing the market to USD 1.9 billion as aging populations and minimally-invasive adoption accelerate future outlook beyond historical 4.8% growth rates.

3. Which factors are the key drivers?

Key drivers include increasing pancreatic cancer incidence, expanding ERCP infrastructure, shift toward fully-covered metal stents, and bundled payment models that favor single-setting biliary decompression procedures.

4. What challenges constrain the market?

Reimbursement compression, stent occlusion leading to repeat procedures, and stringent biocompatibility standards create headwinds, while emerging economies face cost sensitivity favoring plastic variants over premium metal designs.

5. Which regions lead adoption?

North America commands 41% share, followed by Europe at 28%; however, Asia-Pacific is the fastest-growing region with double-digit CAGR propelled by medical tourism and hospital capacity expansion in India and China.

6. Who are the top companies?

Boston Scientific, Cook Medical, and Olympus maintain market leadership through broad metal and plastic portfolios, while BD, Merit Medical, and Taewoong Medical compete on differentiated anti-migration and drug-eluting technologies.

7. Where are future opportunities?

Biodegradable stents, combination drug-device products, and disposable delivery systems represent high-growth niches, while ambulatory surgery center penetration in the U.S. opens cost-effective outpatient biliary intervention pathways.

8. How is technology impacting the market?

Nitinol metallurgy advances allow ultra-thin 6 Fr delivery, while AI-guided ERCP navigation reduces procedure time; 3-D printed patient-specific stents are entering trials, promising personalized biliary anatomy fit and longer patency.

9. What is the regulatory landscape?

FDA’s 510(k) pathway requires substantial equivalence emphasizing patency data; EU MDR ups clinical evidence, prompting post-market surveillance studies, while Japan’s PMDA fast-tracks breakthrough stents with conditional approval.

10. Will pricing pressures persist?

Yes, hospital value-analysis committees increasingly benchmark cost per day of patency, pushing suppliers to bundle accessories and offer volume-based contracts, accelerating average selling price erosion 2–3% annually.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Digestive System Biliary Stent Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	380.00 million
Revenue forecast in 2033	570.05 million
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Allium; Bard; Medtronic; Aohua Endoscopy; Medi-Globe; Merit Medical Systems; ENDOCOR; InSitu Technologies; M.I.TECH; Endotech; PAULDRACH medical; Changzhou Health Microport Medical Device; Dispomedica; Luda Medica; ELLA-CS; Shanghai INNOVEX Medical Devices; optimed; Medinol; Braile Biomédica
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options